List of works - Raashid Ahmed Luqmani

2012 Provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative.

scientific article published in April 2012

2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative

scientific article published in April 2012

2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides

scientific article

A cross-sectional study of the Birmingham Vasculitis Activity Score version 3 in systemic vasculitis.

scientific article published on 13 December 2010

A disease-specific activity index for Wegener's granulomatosis: modification of the Birmingham Vasculitis Activity Score. International Network for the Study of the Systemic Vasculitides (INSSYS)

scientific article published on 01 April 2001

A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis

scientific article

ACR/EULAR-endorsed study to develop Diagnostic and Classification Criteria for Vasculitis (DCVAS).

scientific article published on 31 August 2013

An approach to the diagnosis and management of systemic vasculitis.

scientific article published on 12 January 2010

An unusual cause of death in Wegener's granulomatosis

scientific article published on May 2006

Assessing disease activity in the systemic vasculitides

scientific article

Autoimmune markers for the diagnosis of rheumatoid arthritis in primary care: primary care diagnostic technology update

scientific article published on October 2013

BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis

scientific article published on 11 April 2014

BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis

scientific article published on 5 September 2007

BSR and BHPR guidelines on the use of rituximab in rheumatoid arthritis

scientific article published on 04 May 2011

BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies

scholarly article by T. Ding et al published 12 September 2010 in Rheumatology

British Society for Rheumatology and british health professionals in Rheumatology guideline for the management of rheumatoid arthritis (the first two years).

scientific article published on 13 July 2006

Can We Identify Patients with Microscopic Polyangiitis Who Are at Risk of Relapse?

scientific article published on 01 March 2012

Cardiovascular involvement in primary systemic vasculitis.

scientific article published on June 2009

Comparison of disease activity measures for anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis

scientific article

Current state of tumour necrosis factor {alpha} blockade in Wegener's granulomatosis.

scientific article published on November 2005

Current status of outcome measure development in vasculitis

scientific article published on 15 January 2014

Damage assessment in ANCA-associated vasculitis.

scientific article published on December 2012

Damage caused by Wegener's granulomatosis and its treatment: prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET).

scientific article

Damage in the anca-associated vasculitides: long-term data from the European vasculitis study group (EUVAS) therapeutic trials.

scientific article

Deoxyspergualin in relapsing and refractory Wegener's granulomatosis

scientific article

Developing multidisciplinary guidelines for the management of early rheumatoid arthritis

scientific article published on June 2008

Development and initial validation of the vasculitis damage index for the standardized clinical assessment of damage in the systemic vasculitides

article

Development of outcome measures for large-vessel vasculitis for use in clinical trials: opportunities, challenges, and research agenda

scientific article published on July 2011

Diagnosis and management of ANCA associated vasculitis.

scientific article

Disease activity assessment in childhood vasculitis: development and preliminary validation of the Paediatric Vasculitis Activity Score (PVAS).

scientific article published on 25 October 2012

Disease assessment and management of the vasculitides

scientific article

Disease assessment in systemic vasculitis

scientific article published on 05 February 2015

EULAR recommendations for the management of large vessel vasculitis.

scientific article published on 15 April 2008

EULAR recommendations for the management of primary small and medium vessel vasculitis.

scientific article published on 15 April 2008

EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis.

scientific article published on 23 June 2016

Estimating the diagnostic accuracy of rheumatoid factor in UK primary care: a study using the Clinical Practice Research Datalink

scientific article

European therapeutic trials in ANCA-associated systemic vasculitis: disease scoring, consensus regimens and proposed clinical trials EUROPEAN COMMUNITY STUDY GROUP ON CLINICAL TRIALS IN SYSTEMIC VASCULITIS ECSYSVASTRIAL (BMHl-Cr93-1078) ⬇️

scientific article published on 01 July 1995

Evaluation of vasculitis disease activity in Europe

scientific article published on 01 September 2001

Explaining fatigue in ANCA-associated vasculitis.

scientific article published on 4 June 2013

Exploration, Development, and Validation of Patient-reported Outcomes in Antineutrophil Cytoplasmic Antibody-associated Vasculitis Using the OMERACT Process

scientific article (publication date: November 2015)

Feasibility and Construct Validation of the Patient Reported Outcomes Measurement Information System (PROMIS) in Systemic Vasculitis

scientific article published on 01 March 2019

Glucocorticoid treatment and damage in the anti-neutrophil cytoplasm antibody-associated vasculitides: long-term data from the European Vasculitis Study Group trials

scientific article

Granulomatosis with Polyangiitis (Wegener's): An Alternative Name for Wegener's Granulomatosis

scientific article published on 03 March 2011

Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis.

scientific article

Health-related quality of life in patients with newly diagnosed antineutrophil cytoplasmic antibody-associated vasculitis

scientific article

Introduction to, and classification of, the systemic vasculitides.

scientific article

Is it possible to offer evidence-based treatment for systemic vasculitis?

scientific article published in January 2000

Is rheumatoid factor useful in primary care? A retrospective cross-sectional study

scientific article

Long-term damage to the ENT system in Wegener's granulomatosis.

scientific article

Long-term patient survival in ANCA-associated vasculitis

scientific article published on 24 November 2010

Maintenance of clinical remission in ANCA-associated vasculitis

scientific article published on 13 November 2012

Markers for work disability in anti-neutrophil cytoplasmic antibody-associated vasculitis.

scientific article

Medical student appraisal of interactive computer-assisted learning programs embedded in a general pathology course

scientific article published in August 2000

Missing laboratory test data in electronic general practice records: analysis of rheumatoid factor recording in the clinical practice research datalink.

scientific article

Modification and validation of the Birmingham Vasculitis Activity Score (version 3)

scientific article published on 03 December 2008

Mortality in Wegener's granulomatosis: a bimodal pattern.

scientific article published on 25 November 2010

Necrotic granulomatous pseudotumours in bilateral resurfacing hip arthoplasties: evidence for a type IV immune response

article

Nomenclature and classification of vasculitis – update on the ACR/EULAR Diagnosis and Classification of Vasculitis Study (DCVAS) ⬇️

scientific article published on May 1, 2011

Optimisation of cyclophosphamide therapy in systemic vasculitis

scientific article published on January 1998

Outcome Measures in ANCA-associated Vasculitis ⬇️

scientific article published on June 15, 2010

Patient-reported outcomes in polymyalgia rheumatica

scientific article published on 15 March 2012

Peripheral neuropathy in ANCA-associated vasculitis: outcomes from the European Vasculitis Study Group trials.

scientific article published on 02 September 2011

Pharmacotherapy of vasculitis.

scientific article published on June 2009

Pleural Wegener’s granulomatosis: a rare presentation

scientific article published on 01 February 2009

Progress towards a core set of outcome measures in small-vessel vasculitis. Report from OMERACT 9.

scientific article

Pseudoporphyria and nonsteroidal antiinflammatory agents in children with juvenile idiopathic arthritis

scientific article published in November 2000

Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up.

scientific article

Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis

scientific article published in August 2005

Recommendations for the use of rituximab in anti-neutrophil cytoplasm antibody-associated vasculitis.

scientific article published on 25 May 2011

Recurrent inflammatory stenosis of the M1 segment: diagnostic and therapeutic considerations.

scientific article published on 27 September 2011

Rituximab in combination with corticosteroids for the treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis: a NICE single technology appraisal

scientific article

Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis

scientific article published on July 2010

Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial

scientific article published on 4 March 2015

State of the art in the treatment of systemic vasculitides

scientific article

Systemic vasculitis--is it time to reclassify?

scientific article published on 20 July 2010

The OMERACT core set of outcome measures for use in clinical trials of ANCA-associated vasculitis.

scientific article published on July 2011

The RUDY study platform - a novel approach to patient driven research in rare musculoskeletal diseases

scientific article

The Role of Ultrasound Compared to Biopsy of Temporal Arteries in the Diagnosis and Treatment of Giant Cell Arteritis (TABUL): a diagnostic accuracy and cost-effectiveness study.

scientific article published on November 2016

The characterisation and determinants of quality of life in ANCA associated vasculitis.

scientific article

The impact of 18F-FDG PET on the management of patients with suspected large vessel vasculitis.

scientific article published on 10 November 2011

The phenotype of circulating follicular-helper T cells in patients with rheumatoid arthritis defines CD200 as a potential therapeutic target

scientific article

The relative risk of aortic aneurysm in patients with giant cell arteritis compared with the general population of the UK.

scientific article published on 4 October 2013

The role of biologic therapies in the management of systemic vasculitis.

scientific article published on 20 February 2006

Time to focus on outcome assessment tools for childhood vasculitis

scientific article

Updating the British Society for Rheumatology guidelines for anti-tumour necrosis factor therapy in adult rheumatoid arthritis (again)

scientific article published on 09 March 2006

Vasculitis: an update.

scientific article

Which Patients with Giant Cell Arteritis Will Develop Cardiovascular or Cerebrovascular Disease? A Clinical Practice Research Datalink Study.

scientific article published on 15 April 2016

Why we need guidelines for clinical trials in vasculitis and systemic lupus erythematosus

scientific article published on May 2007

Yersinia arthritis with erythema nodosum.

scientific article published on May 1986

List of works by Raashid Ahmed Luqmani

2012 Provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative.

2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative

2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides

A cross-sectional study of the Birmingham Vasculitis Activity Score version 3 in systemic vasculitis.

A disease-specific activity index for Wegener's granulomatosis: modification of the Birmingham Vasculitis Activity Score. International Network for the Study of the Systemic Vasculitides (INSSYS)

A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis

ACR/EULAR-endorsed study to develop Diagnostic and Classification Criteria for Vasculitis (DCVAS).

An approach to the diagnosis and management of systemic vasculitis.

An unusual cause of death in Wegener's granulomatosis

Assessing disease activity in the systemic vasculitides

Autoimmune markers for the diagnosis of rheumatoid arthritis in primary care: primary care diagnostic technology update

BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis

BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis

BSR and BHPR guidelines on the use of rituximab in rheumatoid arthritis

BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies

British Society for Rheumatology and british health professionals in Rheumatology guideline for the management of rheumatoid arthritis (the first two years).

Can We Identify Patients with Microscopic Polyangiitis Who Are at Risk of Relapse?

Cardiovascular involvement in primary systemic vasculitis.

Comparison of disease activity measures for anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis

Current state of tumour necrosis factor {alpha} blockade in Wegener's granulomatosis.

Current status of outcome measure development in vasculitis

Damage assessment in ANCA-associated vasculitis.

Damage caused by Wegener's granulomatosis and its treatment: prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET).

Damage in the anca-associated vasculitides: long-term data from the European vasculitis study group (EUVAS) therapeutic trials.

Deoxyspergualin in relapsing and refractory Wegener's granulomatosis

Developing multidisciplinary guidelines for the management of early rheumatoid arthritis

Development and initial validation of the vasculitis damage index for the standardized clinical assessment of damage in the systemic vasculitides

Development of outcome measures for large-vessel vasculitis for use in clinical trials: opportunities, challenges, and research agenda

Diagnosis and management of ANCA associated vasculitis.

Disease activity assessment in childhood vasculitis: development and preliminary validation of the Paediatric Vasculitis Activity Score (PVAS).

Disease assessment and management of the vasculitides

Disease assessment in systemic vasculitis

EULAR recommendations for the management of large vessel vasculitis.

EULAR recommendations for the management of primary small and medium vessel vasculitis.

EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis.

Estimating the diagnostic accuracy of rheumatoid factor in UK primary care: a study using the Clinical Practice Research Datalink

European therapeutic trials in ANCA-associated systemic vasculitis: disease scoring, consensus regimens and proposed clinical trials EUROPEAN COMMUNITY STUDY GROUP ON CLINICAL TRIALS IN SYSTEMIC VASCULITIS ECSYSVASTRIAL (BMHl-Cr93-1078) ⬇️

Evaluation of vasculitis disease activity in Europe

Explaining fatigue in ANCA-associated vasculitis.

Exploration, Development, and Validation of Patient-reported Outcomes in Antineutrophil Cytoplasmic Antibody-associated Vasculitis Using the OMERACT Process

Feasibility and Construct Validation of the Patient Reported Outcomes Measurement Information System (PROMIS) in Systemic Vasculitis

Glucocorticoid treatment and damage in the anti-neutrophil cytoplasm antibody-associated vasculitides: long-term data from the European Vasculitis Study Group trials

Granulomatosis with Polyangiitis (Wegener's): An Alternative Name for Wegener's Granulomatosis

Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis.

Health-related quality of life in patients with newly diagnosed antineutrophil cytoplasmic antibody-associated vasculitis

Introduction to, and classification of, the systemic vasculitides.

Is it possible to offer evidence-based treatment for systemic vasculitis?

Is rheumatoid factor useful in primary care? A retrospective cross-sectional study

Long-term damage to the ENT system in Wegener's granulomatosis.

Long-term patient survival in ANCA-associated vasculitis

Maintenance of clinical remission in ANCA-associated vasculitis

Markers for work disability in anti-neutrophil cytoplasmic antibody-associated vasculitis.

Medical student appraisal of interactive computer-assisted learning programs embedded in a general pathology course

Missing laboratory test data in electronic general practice records: analysis of rheumatoid factor recording in the clinical practice research datalink.

Modification and validation of the Birmingham Vasculitis Activity Score (version 3)

Mortality in Wegener's granulomatosis: a bimodal pattern.

Necrotic granulomatous pseudotumours in bilateral resurfacing hip arthoplasties: evidence for a type IV immune response

Nomenclature and classification of vasculitis – update on the ACR/EULAR Diagnosis and Classification of Vasculitis Study (DCVAS) ⬇️

Optimisation of cyclophosphamide therapy in systemic vasculitis

Outcome Measures in ANCA-associated Vasculitis ⬇️

Patient-reported outcomes in polymyalgia rheumatica

Peripheral neuropathy in ANCA-associated vasculitis: outcomes from the European Vasculitis Study Group trials.

Pharmacotherapy of vasculitis.

Pleural Wegener’s granulomatosis: a rare presentation

Progress towards a core set of outcome measures in small-vessel vasculitis. Report from OMERACT 9.

Pseudoporphyria and nonsteroidal antiinflammatory agents in children with juvenile idiopathic arthritis

Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up.

Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis

Recommendations for the use of rituximab in anti-neutrophil cytoplasm antibody-associated vasculitis.

Recurrent inflammatory stenosis of the M1 segment: diagnostic and therapeutic considerations.

Rituximab in combination with corticosteroids for the treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis: a NICE single technology appraisal

Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis

Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial

State of the art in the treatment of systemic vasculitides

Systemic vasculitis--is it time to reclassify?

The OMERACT core set of outcome measures for use in clinical trials of ANCA-associated vasculitis.

The RUDY study platform - a novel approach to patient driven research in rare musculoskeletal diseases

The Role of Ultrasound Compared to Biopsy of Temporal Arteries in the Diagnosis and Treatment of Giant Cell Arteritis (TABUL): a diagnostic accuracy and cost-effectiveness study.

The characterisation and determinants of quality of life in ANCA associated vasculitis.